Table 2.
Reference | Specimen source | Diagnosis | Stage | n | Correlation with survival |
Yoon et al., 2011 | Peripheral blood | NSCLC | I–III | 79 | Negative |
Martins et al., 2009 | Histopathology | NSCLC | IIIB–IV | 51 | Positive |
Barletta et al., 2009 | Histopathology | ADC | I–IV | 89 | Positive |
Wang et al., 2007 | Histopathology | BAC | III | 81 | Positive |
Berghmans et al., 2006 | Ten-published articles | Meta-analysis | I–IV | 10 | Positive |
Barlesi et al., 2005 | Histopathology | ADC | I–IV | 106 | Positive |
Stenhouse et al., 2004 | Histopathology | Lung tumor | Unknown | 165 | NS |
Au et al., 2004 | Histopathology | NSCLC | Unknown | 284 | NS |
Shah et al., 2004 | Histopathology | NSCLC | I–III | 63 | NS |
Saad et al., 2004 | Histopathology | ADC | I | 100 | Positive |
Myong, 2003 | Histopathology | NSCLC | I–III | 65 | Positive |
Tan et al., 2003 | Histopathology | NSCLC | I–III | 126 | Positive |
Haque et al., 2002 | Histopathology | NSCLC | I–III | 57 | Positive |
Pelosi et al., 2001 | Histopathology | NSCLC | I | 222 | NS |
Puglisi et al., 1999 | Histopathology | NSCLC | I–III | 88 | Negative |
NS: not significant; n: number of patients